Cubist Pharmaceuticals Announces Enhanced Careers Section of Corporate Website.LEXINGTON, Mass. -- Cubist Pharmaceuticals, Inc. (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on : CBST CBST Center for Biophotonics Science and Technology CBST Congregation Beth Simcha Torah (NYC) CBST Complete Binary Search Tree ) is pleased to announce the re-launch of its corporate website and the introduction of the newly created Careers section. Our goal is to enhance the job seekers' experience with both active and passive candidate-centric features and advanced job search capabilities. Working in partnership with iMarc, a full service firm, providing website strategy, design, and programming, the visitor experience was created to provide: * Targeted job search functionality with personalized job management and candidate application tools * Networking and candidate relationship building features * An introduction to our employees inside and outside of work, highlighting the diversity of employee backgrounds and insight into professional development opportunities * Access to our corporate video, illuminating the Cubist culture and the focus on improving health and saving lives * Information on our Total Rewards philosophy * Information on our recruitment programs In addition to these enhancements, the design and interactive menus make navigation more intuitive and user-friendly. Cubist is dedicated to continue improving resources for our web community, so expect to see more features implemented in the future. In addition, we value your comments and suggestions to help us understand your needs and improve our website. Please take a moment to provide your thoughts, ideas and suggestions on your Cubist website experience by completing our online survey here. About Cubist Cubist Pharmaceuticals, Inc. is a biopharmaceutical company focused on the research, development, and commercialization of pharmaceutical products that address unmet medical needs in the acute care environment. In the U.S., Cubist markets CUBICIN[R] (daptomycin for injection), the first antibiotic in a new class of anti-infectives called lipopeptides. In July 2008, Cubist entered into an agreement with AstraZeneca to promote their established antibiotic, MERREM[R] I.V. (meropenem for injection) in the U.S. The Cubist product pipeline includes ecallantide, a recombinant human protein in Phase 2 clinical trials phase 2 clinical trial Phase 2 study. See Phase study. -- CONSERV[TM]-1 and CONSERV[TM]-2 -- for the reduction of blood loss during cardiac surgery Cardiac surgery is surgery on the heart and/or great vessels performed by a cardiac surgeon. Frequently, it is done to treat complications of ischemic heart disease (for example, coronary artery bypass grafting), correct congenital heart disease, or treat valvular heart disease , and two Phase 1 programs that address unmet medical needs, one in CDAD CDAD Clostridium Difficile-Associated Diarrhea CDAD Component Data Administrator (Clostridium clostridium Any of the rod-shaped, usually gram-positive bacteria (see gram stain) that make up the genus Clostridium. They are found in soil, water, and the intestinal tracts of humans and other animals. Some species grow only in the complete absence of oxygen. difficile-associated diarrhea) and the other in multi-drug resistant (MDR MDR, n See multidrug resistance. MDR, n the abbreviation for minimum daily requirement, specifically the Minimum Daily Requirements for Specific Nutrients compiled by the United States Food and Drug Administration. ) Gram-negative infections. In addition, the Company, in collaboration with Alnylam Pharmaceuticals Alnylam Pharmaceuticals Inc. (NYSE: ALNY), a biopharmaceutical company, engages in the development and commercialization of therapeutic products based on RNA interference (RNAi) in the United States. , Inc. (Cambridge, MA), has a pre-IND and a Phase 2 program underway in novel treatments for respiratory syncytial virus infections Respiratory Syncytial Virus Infection Definition Respiratory syncytial virus (RSV) is a virus that can cause severe lower respiratory infections in children under the age of two, and milder upper respiratory infections in older children and adults. using Alnylam's RNA-interference technology. Cubist is headquartered in Lexington, MA. Additional information can be found at Cubist's web site at www.cubist.com. Photos/Multimedia Gallery Available: http://www.businesswire.com/cgi-bin/mmg.cgi?eid=6060968&lang=en |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion